VERTEX PHARMACEUTICALS INC / MA: operating_income
| Value | {"amount": -903448000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | superseded |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:18.745941+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8c466cc0-ef09-4d7c-9150-93c0771dccd1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875320-14-000015Retrieved: 2026-08-19T08:42:18.745941+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/operating-income/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8c466cc0-ef09-4d7c-9150-93c0771dccd1
History
- no predecessors — first report